Clinical Trial Update: A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants [Phase 4]

View source ↗

Summary

A Phase 4 real-world study evaluating early PEG-rhGH therapy on cognitive development in small-for-gestational-age infants is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small For Gestational Age Infant

Drugs mentioned

• PEG-rhGH (pegylated recombinant human growth hormone)

Snippet

Sponsor: Tongji Hospital | Conditions: Small for Gestational Age Infant, Growth Hormone Treatment | Phase 4 | Status: RECRUITING